245 related articles for article (PubMed ID: 18189345)
1. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma.
Ressom HW; Varghese RS; Goldman L; An Y; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Drake SK; Goldman R
J Proteome Res; 2008 Feb; 7(2):603-10. PubMed ID: 18189345
[TBL] [Abstract][Full Text] [Related]
2. Analysis of MALDI-TOF mass spectrometry data for detection of glycan biomarkers.
Ressom HW; Varghese RS; Goldman L; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Goldman R
Pac Symp Biocomput; 2008; ():216-27. PubMed ID: 18229688
[TBL] [Abstract][Full Text] [Related]
3. Integrated peptide and glycan biomarker discovery using MALDI-TOF mass spectrometry.
Varghese RS; Goldman L; An Y; Loffredo CA; Abdel-Hamid M; Kyselova Z; Mechref Y; Novotny M; Drake SK; Goldman R; Ressom HW
Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():3791-4. PubMed ID: 19163537
[TBL] [Abstract][Full Text] [Related]
4. Detection of hepatocellular carcinoma using glycomic analysis.
Goldman R; Ressom HW; Varghese RS; Goldman L; Bascug G; Loffredo CA; Abdel-Hamid M; Gouda I; Ezzat S; Kyselova Z; Mechref Y; Novotny MV
Clin Cancer Res; 2009 Mar; 15(5):1808-13. PubMed ID: 19223512
[TBL] [Abstract][Full Text] [Related]
5. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z
Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma.
Orvisky E; Drake SK; Martin BM; Abdel-Hamid M; Ressom HW; Varghese RS; An Y; Saha D; Hortin GL; Loffredo CA; Goldman R
Proteomics; 2006 May; 6(9):2895-902. PubMed ID: 16586431
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
8. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data.
Tang Z; Varghese RS; Bekesova S; Loffredo CA; Hamid MA; Kyselova Z; Mechref Y; Novotny MV; Goldman R; Ressom HW
J Proteome Res; 2010 Jan; 9(1):104-12. PubMed ID: 19764807
[TBL] [Abstract][Full Text] [Related]
9. Peak selection from MALDI-TOF mass spectra using ant colony optimization.
Ressom HW; Varghese RS; Drake SK; Hortin GL; Abdel-Hamid M; Loffredo CA; Goldman R
Bioinformatics; 2007 Mar; 23(5):619-26. PubMed ID: 17237065
[TBL] [Abstract][Full Text] [Related]
10. High-throughput quantitative profiling of serum N-glycome by MALDI-TOF mass spectrometry and N-glycomic fingerprint of liver fibrosis.
Kam RK; Poon TC; Chan HL; Wong N; Hui AY; Sung JJ
Clin Chem; 2007 Jul; 53(7):1254-63. PubMed ID: 17510303
[TBL] [Abstract][Full Text] [Related]
11. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
[TBL] [Abstract][Full Text] [Related]
12. Prediction of chronic hepatitis B, liver cirrhosis and hepatocellular carcinoma by SELDI-based serum decision tree classification.
Cui J; Kang X; Dai Z; Huang C; Zhou H; Guo K; Li Y; Zhang Y; Sun R; Chen J; Li Y; Tang Z; Uemura T; Liu Y
J Cancer Res Clin Oncol; 2007 Nov; 133(11):825-34. PubMed ID: 17516088
[TBL] [Abstract][Full Text] [Related]
13. Biomarker discovery for early detection of hepatocellular carcinoma in hepatitis C-infected patients.
Mustafa MG; Petersen JR; Ju H; Cicalese L; Snyder N; Haidacher SJ; Denner L; Elferink C
Mol Cell Proteomics; 2013 Dec; 12(12):3640-52. PubMed ID: 24008390
[TBL] [Abstract][Full Text] [Related]
14. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
Ying X; Han SX; Wang JL; Zhou X; Jin GH; Jin L; Wang H; Wu L; Zhang J; Zhu Q
Diagn Pathol; 2013 Aug; 8():130. PubMed ID: 23915185
[TBL] [Abstract][Full Text] [Related]
15. Increased concentrations of apo A-I and apo A-II fragments in the serum of patients with hepatocellular carcinoma by magnetic beads-assisted MALDI-TOF mass spectrometry.
Liu Y; Sogawa K; Sunaga M; Umemura H; Satoh M; Kazami T; Yoshikawa M; Tomonaga T; Yokosuka O; Nomura F
Am J Clin Pathol; 2014 Jan; 141(1):52-61. PubMed ID: 24343737
[TBL] [Abstract][Full Text] [Related]
16. Candidate markers for the detection of hepatocellular carcinoma in low-molecular weight fraction of serum.
Goldman R; Ressom HW; Abdel-Hamid M; Goldman L; Wang A; Varghese RS; An Y; Loffredo CA; Drake SK; Eissa SA; Gouda I; Ezzat S; Moiseiwitsch FS
Carcinogenesis; 2007 Oct; 28(10):2149-53. PubMed ID: 17724376
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of hepatitis B virus-related hepatocellular carcinoma with magnetic bead-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu T; Xue R; Huang X; Zhang D; Dong L; Wu H; Shen X
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):542-50. PubMed ID: 21659380
[TBL] [Abstract][Full Text] [Related]
18. Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.
Saito Y; Oba N; Nishinakagawa S; Mizuguchi Y; Kojima T; Nomura K; Nakatsura T
Oncol Rep; 2010 May; 23(5):1325-30. PubMed ID: 20372847
[TBL] [Abstract][Full Text] [Related]
19. LC-MS profiling of N-Glycans derived from human serum samples for biomarker discovery in hepatocellular carcinoma.
Tsai TH; Wang M; Di Poto C; Hu Y; Zhou S; Zhao Y; Varghese RS; Luo Y; Tadesse MG; Ziada DH; Desai CS; Shetty K; Mechref Y; Ressom HW
J Proteome Res; 2014 Nov; 13(11):4859-68. PubMed ID: 25077556
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis.
He J; Zeng ZC; Xiang ZL; Yang P
World J Gastroenterol; 2014 Mar; 20(11):3025-32. PubMed ID: 24659894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
